Literature DB >> 19660494

Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: a public health perspective.

Satvinder S Dhaliwal1, Timothy A Welborn.   

Abstract

BACKGROUND: Our objective is to develop a parsimonious model to predict coronary heart disease (CHD) and cardiovascular disease (CVD) deaths using individual components of the Framingham risk score plus measures of central obesity.
METHODS: 15 year mortality follow-up of 8662 representative Australian adults in the National Heart Foundation Risk Factor Prevalence Survey of 1989, excluding those with a baseline history of heart disease, stroke or diabetes. Measures included blood pressure, fasting lipids, smoking history, body mass index (BMI), waist circumference (WC) and waist to hip ratio (WHR). Multivariable logistic regression was used to assess the effects of the Framingham risk variables and central obesity variables on cardiovascular disease mortality.
RESULTS: Smoking status, high density lipoprotein cholesterol (HDL-C) and the total cholesterol (TC) to HDL-C ratio were significant univariate predictors of CHD deaths. These together with systolic blood pressure were significant predictors of CVD deaths. The obesity measures of WC and WHR were significant univariate predictors but BMI was not. In multivariable analyses, only smoking status and waist to hip ratio were identified as key independent risk factors for CHD and CVD deaths, although TC to HDL-C ratio contributed minimally to CHD deaths. Receiver operator characteristic (ROC) curves for the Framingham risk score in comparison to the WHR plus smoking model were virtually identical, with no added effect of the lipid ratio.
CONCLUSION: The preferred model for predicting CHD and CVD deaths uses central obesity plus smoking with no added influence of measured lipids or blood pressure. A public health focus on identifying and modifying central obesity is at least as important as the measurement and treatment of lipids and hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660494     DOI: 10.1016/j.ypmed.2009.07.019

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

1.  Health-related outcomes associated with patterns of risk factors in primary care patients.

Authors:  Jennifer S Funderburk; Stephen A Maisto; Allison K Labbe
Journal:  J Clin Psychol Med Settings       Date:  2014-03

2.  Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial.

Authors:  Lisa M Davis; Christopher Coleman; Jessica Kiel; Joni Rampolla; Tammy Hutchisen; Laura Ford; Wayne S Andersen; Andrea Hanlon-Mitola
Journal:  Nutr J       Date:  2010-03-11       Impact factor: 3.271

3.  Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan.

Authors:  Wuan-Szu Wang; Mark L Wahlqvist; Chih-Cheng Hsu; Hsing-Yi Chang; Wan-Chi Chang; Chu-Chih Chen
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

4.  Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study.

Authors:  Louise G H Goh; Satvinder S Dhaliwal; Timothy A Welborn; Andy H Lee; Phillip R Della
Journal:  BMJ Open       Date:  2014-02-06       Impact factor: 2.692

Review 5.  Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges.

Authors:  Omotayo O Erejuwa; Siti A Sulaiman; Mohd S Ab Wahab
Journal:  Int J Mol Sci       Date:  2014-03-07       Impact factor: 5.923

6.  Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study.

Authors:  Louise Gek Huang Goh; Timothy Alexander Welborn; Satvinder Singh Dhaliwal
Journal:  BMC Womens Health       Date:  2014-09-26       Impact factor: 2.809

7.  Rethinking the causes of pilonidal sinus disease: a matched cohort study.

Authors:  Dietrich Doll; Imke Brengelmann; Patrick Schober; Andreas Ommer; Friederike Bosche; Apostolos E Papalois; Sven Petersen; Dirk Wilhelm; Johannes Jongen; Markus M Luedi
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

8.  Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese.

Authors:  Wen-Yuan Lin; F Xavier Pi-Sunyer; Chiu-Shong Liu; Chia-Ing Li; Lance E Davidson; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Electro-acupuncture for central obesity: randomized, patient-assessor blinded, sham-controlled clinical trial protocol.

Authors:  Linda L D Zhong; Xingyao Wu; Tsz Fung Lam; Ying Ping Wong; Peihua Cao; Emily Yen Wong; Shipping Zhang; Zhaoxiang Bian
Journal:  BMC Complement Med Ther       Date:  2021-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.